As discussed in the previous paragraph, the transcription factor EGR-1 has been shown to associate with the promoter of hPar1 in prostate cancer, leading to hPar1 overexpression and enhancement of invasive properties [9]. This evidence concerns the gene EGR1 and Familial prostate cancer.